pauline williams
Pauline Williams

Head of Global Health R&D, GSK

Responsibility

Responsible business is how we do business

Being commercially successful and operating responsibly is how we will generate sustainable returns for our shareholders and deliver on our purpose, to help patients and consumers around the world, do more, feel better and live longer. 

In September 2018, we announced a new set of commitments across three focus areas, to deliver the greatest possible long-term impact in improving health around the world.

Our purpose is to help people do more, feel better, live longer

By using our

science and technology to address health needs

By making our products

affordable and available

By being a

modern employer

Being a responsible business

How we will report our performance

We will share our progress by reporting against our new commitments each year starting in 2019, for the 2018 year. A summary of progress against our commitments can be found here, and further detail can be found in our Annual Report.

Sustainable development

The UN Sustainable Development Goals (SDGs) set out a vision for ending poverty, hunger, inequality and protecting the Earth’s natural resources by 2030. Realising this ambition will require private sector, governments and civil society to play their part and work together in new and innovative ways.

As a science-led global healthcare company Goal 3, Good Health & Wellbeing, is where we can make the most important contribution. The scale and nature of our business mean that we also contribute to a number of the UN’s goals through our everyday operations. For examples of how we contribute to the SDGs please download our SDG factsheet.

Our governance structure

board of committees
Board Committees have been established as set out above (graphic from our Annual report, 2017)

Our Board-level Corporate Responsibility Committee (CRC) oversees our responsible business activities. It meets four times a year to provide high-level guidance and reviews performance against our commitments. Both the Chairman and CEO are among its members and Non-Executive Director, Lynn Elsenhans, is Chair of the CRC.

Management of key non-financial risks is governed by our Audit and Risk Committee. The Audit and Assurance team supports this committee by providing an independent view to the Board and senior management of how risk is being managed across the business consistent with an agreed Assurance Plan.

Your feedback counts

We welcome your feedback on our responsible business performance and reporting. You can also request to receive regular updates on our progress. Please contact us at csr.contact@gsk.com